Greenberg Traurig advised Zeem Solutions on the deal. Zeem Solutions, a zero-emission “fleet-as-a-service” provider, in its $50 million equity investment agreement with a fund managed by...
You must be a Standard 1 Year member to access this content.
Goodwin advised Royalty Pharma plc on the deal. Royalty Pharma plc (Nasdaq: RPRX) announced its definitive agreement to acquire a royalty interest in TRELEGY ELLIPTA (Trelegy) from...
You must be a Standard 1 Year member to access this content.
Goodwin advised Bregal Sagemount on the deal while Holland & Knight represented BuildingLink. Bregal Sagemount announced its strategic growth investment in BuildingLink. Sagemount is a leading growth-focused...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised CathWorks on the deal. CathWorks announced its acquisition option agreement and co-promotion agreement with Medtronic (NYSE: MDT). Under the acquisition option agreement, Medtronic will...
You must be a Standard 1 Year member to access this content.
Dentons assisted Fort Partners, Norton Rose Fulbright and Goodwin represented Four Seasons Hotels and Resorts, DLA Piper represented the seller, Bisogni Miccoli & Associati represented DeA...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery and Bredin Prat advised Five Arrows Principal Investments on the deal. Goodwin advised Latour Capital, Barings and Arcmont Asset Management. Latour Capital...
You must be a Standard 1 Year member to access this content.
Skadden advised Theravance Biopharma, while Goodwin Procter advised Royalty Pharma on the deal. Willkie Farr & Gallagher advised Innoviva on the sale of its stake in...
You must be a Standard 1 Year member to access this content.
Goodwin advised HqO on the deal. HqO announced its acquisition of Leesman. HqO is an industry leading tenant and workplace experience platform transforming how people connect with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised ODLO International on the deal. ODLO International (“ODLO”), a Swiss performance brand in Monte Rosa Capital’s portfolio, announced its agreement to acquire British sailing...
You must be a Standard 1 Year member to access this content.
Goodwin advised Protocol Labs on the deal. Protocol Labs announced its leading investment in Mona’s $14.6 million Series A funding round. The round was co-led by Archetype...
You must be a Standard 1 Year member to access this content.
Goodwin advised Micropep Technologies on the deal. Micropep Technologies, an ag-biotech company developing revolutionary biological micropeptide-based solutions for agriculture, announced the €8.75 million additional new Series A...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Blueprint Medicines Corporation on the deal while Cooley represented Sixth Street. Blueprint Medicines Corporation (NASDAQ: BPMC) announced its strategic financing collaborations with Sixth...
You must be a Standard 1 Year member to access this content.
